Barragry J M, Long R G, France M W, Wills M R, Boucher B J, Sherlock S
Gut. 1979 Jul;20(7):559-64. doi: 10.1136/gut.20.7.559.
The intestinal absorption of (3H)cholecalciferol was studied in five patients with alcoholic liver disease, six patients with primary biliary cirrhosis, and 15 healthy subjects. The rate of appearance in plasma of (3H)cholecalciferol after oral ingestion and the subsequent appearance of (3H) polar metabolites in the alcoholic subjects were similar to those in the healthy subjects. In subjects with primary biliary cirrhosis the rate of appearance in plasma of (3H)cholecalciferol was significantly reduced. The rate of appearance of labelled polar metabolites of cholecalciferol was also lower in this group, suggesting that increased removal of labelled vitamin by conversion into more polar metabolites could not account for the reduced plasma (3H)cholecalciferol response. It is suggested that intestinal absorption of cholecalciferol is usually normal in alcoholic liver disease but impaired in primary biliary cirrhosis. Hepatic 25-hydroxylation is normal in alcoholic liver disease but may be defective in primary biliary cirrhosis.
对5例酒精性肝病患者、6例原发性胆汁性肝硬化患者和15名健康受试者进行了(3H)胆钙化醇的肠道吸收研究。口服后(3H)胆钙化醇在血浆中的出现率以及酒精性受试者中随后出现的(3H)极性代谢产物与健康受试者相似。在原发性胆汁性肝硬化患者中,(3H)胆钙化醇在血浆中的出现率显著降低。该组中胆钙化醇标记的极性代谢产物的出现率也较低,这表明通过转化为更多极性代谢产物而增加的标记维生素清除率并不能解释血浆(3H)胆钙化醇反应的降低。提示酒精性肝病中胆钙化醇的肠道吸收通常正常,但原发性胆汁性肝硬化中受损。酒精性肝病中肝脏的25-羟化正常,但原发性胆汁性肝硬化中可能存在缺陷。